Repository logo
 

Cryptic mitochondrial DNA mutations coincide with mid-late life and are pathophysiologically informative in single cells across tissues and species.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Ageing is associated with a range of chronic diseases and has diverse hallmarks. Mitochondrial dysfunction is implicated in ageing, and mouse-models with artificially enhanced mitochondrial DNA mutation rates show accelerated ageing. A scarcely studied aspect of ageing, because it is invisible in aggregate analyses, is the accumulation of somatic mitochondrial DNA mutations which are unique to single cells (cryptic mutations). We find evidence of cryptic mitochondrial DNA mutations from diverse single-cell datasets, from three species, and discover: cryptic mutations constitute the vast majority of mitochondrial DNA mutations in aged post-mitotic tissues, that they can avoid selection, that their accumulation is consonant with theory we develop, hitting high levels coinciding with species specific mid-late life, and that their presence covaries with a majority of the hallmarks of ageing including protein misfolding and endoplasmic reticulum stress. We identify mechanistic links to endoplasmic reticulum stress experimentally and further give an indication that aged brain cells with high levels of cryptic mutations show markers of neurodegeneration and that calorie restriction slows the accumulation of cryptic mutations.

Description

Acknowledgements: We thank the Systems and Signals group at Imperial College London for discussions. This research was funded by Leverhulme (RPG-2018-408), EPSRC (EP/N014529/1), and Wellcome (224486/Z/21/Z). F.K. is supported as an Add-on Fellow for Interdisciplinary Life Sciences by the Joachim Herz Foundation. A.G.D. is a Ramon y Cajal Fellow (RYC2020-029291-I) who receives support from the Spanish Ministry of Science (PID2020-114709RA-I00) and Comunidad de Madrid (Spain) (2019-T1BMD-14236). P.F.C. is a Wellcome Trust Principal Research Fellow (212219/Z/18/Z), and a UK NIHR Senior Investigator, who receives support from the Medical Research Council Mitochondrial Biology Unit (MC_UU_00015/9), the Medical Research Council (MRC) International Centre for Genomic Medicine in Neuromuscular Disease (MR/S005021/1), the Leverhulme Trust (RPG-2018-408), an MRC research grant (MR/S035699/1), an Alzheimer’s Society Project Grant (AS-PG-18b-022). This research was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

Journal Title

Nat Commun

Conference Name

Journal ISSN

2041-1723
2041-1723

Volume Title

16

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
Medical Research Council (MC_UU_00015/7)
Wellcome Trust (212219/Z/18/Z)
MRC (MR/S035699/1)
National Institute for Health and Care Research (IS-BRC-1215-20014)
Wellcome Trust (via Imperial College London) (224486/Z/21/Z)